White Mountain Research Center
30 Jun, 01 PM - 10 Oct, 01 PM
A Double-blind, Randomized and Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of T89 in Prevention and Treatment of Acute Mountain Sickness (AMS) During Rapid Ascent
Visit #63659 @White Mountain Research Center
Approved
Under Project # 43363 | Research
Tasly T-89 High Altitude Studyfaculty - University of California, San Francisco
Reservation Members(s)
Jeffrey Sall
Jun 30 - Jul 5, 2019 (6 days)
Group of 3 Faculty
Jun 30 - Jul 5, 2019 (6 days)
Group of 11 Other
Jun 30 - Jul 5, 2019 (6 days)
Jeffrey Sall
Jul 20 - 25, 2019 (6 days)
Group of 2 Faculty
Jul 20 - 25, 2019 (6 days)
Group of 14 Other
Jul 20 - 25, 2019 (6 days)
Jeffrey Sall
Aug 25 - 30, 2019 (6 days)
Group of 3 Faculty
Aug 25 - 30, 2019 (6 days)
Group of 16 Other
Aug 25 - 30, 2019 (6 days)
Jeffrey Sall
Sep 1 - 6, 2019 (6 days)
Group of 3 Faculty
Sep 1 - 6, 2019 (6 days)
Group of 13 Other
Sep 1 - 6, 2019 (6 days)
Jeffrey Sall
Oct 5 - 10, 2019 (6 days)
Group of 5 Faculty
Oct 5 - 10, 2019 (6 days)
Group of 11 Other
Oct 5 - 10, 2019 (6 days)
Reserve Resources(s) | Create Invoice
Barcroft Station, Room & Board
15
Jun 30 - Jul 5, 2019
Barcroft Station, Room & Board
15
Jul 20 - 25, 2019
Barcroft Station, Room & Board
20
Aug 25 - 30, 2019
Barcroft Station, Room & Board
17
Sep 1 - 6, 2019
Barcroft Station, Room & Board
17
Oct 5 - 10, 2019
Barcroft Station, Room & Board
1
Aug 31 - Sep 1, 2019